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A novel method to link a nascent protein (phenotype) to its mRNA (genotype) covalently through the N-terminus 
was developed. The mRNA harboring amber stop codon at just downstream of initiation site was hybridized 
with hydrazide-modified ssDNA at upstream of coding region and was ligated to the DNA. This construct was 
then modified with 4-acetyl-phenylalanyl amber suppressor tRNA. This modified construct was fused with the 
nascent protein via the phenylalanine derivative when the mRNA uses the amber suppressor tRNA to decode the 
amber stop codon. The obtained fusion molecule was used successfully in selective enrichment experiments. It 
will be applicable for high-through-put screening in evolutionary protein engineering .  I n  c o n t r a s t  t o  f u s i o n  
molecules generated by other methods in which the protein is linked to genotype molecule through the C- 
terminus, our fusion molecule will serve to select a protein for which the C-terminus is essential to be active. 
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1.  Introduction 
In evolutionary protein engineering, in vitro 
selection using a cell-free translation system carries 
advantages of large library size and applicability to 
cytotoxic proteins. Although various in vitro protein 
selection techniques such as in vitro virus [1], mRNA 
display [2] and ribosome display [3] have been 
developed, most of them are the techniques in which 
3’-terminus of the genotype molecule is linked to the 
decoded peptide via its C-terminus. Thus, they are not 
adequate to the evolution of the protein, of which 
C-terminus is essential for its function (such as various 
peptide ligands, protein-protein interaction domain, 
membrane proteins, peptide hormones, etc). Therefore, 
it is worthwhile to devise the method in which the 
genotype molecule is linked to the decoded protein via 
its N-terminus, i.e. C-terminus of the protein is 
displayed freely. 
Also in phage display method, the peptide is 
fused usually at the N-terminus of coat protein. 
However, the display method in which the peptide 
library was fused at the C-terminus of M13 phage 
major coat protein [4,5] and T7 phage D-coat protein 
[6] has been also reported. The carboxyl terminal end 
of PDZ domain-ligands, which is essential to be 
recognized by PDZ domain, was screened [7,8] and 
mapping of the C-terminal epitope of the Alzheimer’s 
disease specific antibody [9] was carried out using 
such carboxyl-terminal phage display.  
Several methods that link the protein to its 
mRNA (or DNA) via N-terminus have been reported. 
Sawata and Taira reported the binding procedure 
between MS2 coat protein dimer fused at N-terminus 
of the protein and the specific recognition sequence in 
its mRNA [10]. Yanagawa and coworkers developed 
the method named “STABLE” in which the 
streptavidin fused at N-terminus of a peptide was 
bound to biotin labeled gene DNA in emulsion [11,12]. 
These methods are simple and effective; however, 
screening condition is limited because its linkage 
between the peptide and its genotype molecule is 
non-covalent. Baskerville and Bartel made the 
ribozyme that catalyzes a phosphoamide bond 
formation between the 5’-terminus of the encoding 
RNA and the N-terminus of the decoded polypeptide 
[13]. Nester and coworkers developed the method that 
employed the property of VirD2 protein, which 
covalently binds to the specific DNA sequence [14]. 
These methods employ a covalent bond to linkage the 
peptide and its genotype molecule; however, these 
have not been applied yet to in vitro selection. 
To date, many studies on the non-natural amino 
acid incorporation into a protein using nonsense 
[15,16] or frame-shift [17] suppression have been 
reported. And recently, these have been applied to in 
vitro protein display methods to introduce the 
mRNA-peptide fusion molecule library containing 
non-natural amino acid [18,19].   
In this article we report the novel method to link 
the N-terminus of the peptide to its mRNA. In our 
method, the mRNA is linked via ssDNA and spacer to 
phenylalanine derivative, which is acylated to amber 
sup tRNA. When this modified mRNA is subjected to a 
cell-free translation system, this phenylalanine 
derivative would be incorporated into the N-terminus Int. J. Biol. Sci. 2007, 3 
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region of the nascent peptide at the amber stop codon 
inserted at the beginning of the encoded region. 
Consequently, C-terminus of the peptide is displayed 
on its mRNA (Fig.1). 
 
Fig. 1. Screening cycle of the mRNA-protein fusion in this study. The dsDNA library is transcribed to mRNA. The mRNA is 
hybridized to the DNA moiety of the linker having hydrazide group and ligated with T4 RNA ligase. Hydrazide group of the ligated 
product and acetyl group of the phenylalanine derivative that is acylated to sup tRNA are ligated chemically and the modified mRNA 
is translated. The modified aminoacyl sup tRNA tends to occupy the A-site of ribosome at UAG codon inserted near downstream of 
initiation codon and the phenylalanine is incorporated into the growing peptide. Thus, linkage between N-terminus of the nascent 
peptide and 5’-terminus of its mRNA is achieved. Screening of mRNA-peptide fusion library according to property of the displayed 
peptide and amplify the genotype molecules of the screened fusions by RT-PCR. 
 
2.  Materials and Methods 
Synthesis of the DNA-linker having a hydrazide 
group 
The DNA-linker having a hydrazide group at 
5’-terminus (hydrazide-linker) was synthesized as 
follows. 5’-NH2-(CH2)6-(CH2CH2O)6-(dA)30-(CH2CH2 
O)6-GGG-(dT-FITC)-CGGGGGGCAAAA-3', where 
(dA)30 is 30 nucleotides of deoxy adenosine, (dT-FITC) 
is fluorescein-modified deoxy thymidine, was 
purchased from Tsukuba Oligo Service Co., Ltd 
(Ibaraki, Japan). Single riboadenosine was added to 
3’-terminus of the oligomer (1.0 nmol) using terminal 
deoxynucleotidyl transferase (24 U, Takara Bio) with 
20 µmol ATP at 37 °C for overnight in 50 µl of supplied 
TdT buffer. The product was purified on P6 column 
( B i o  R a d )  t o  r e m o v e  e x c e s s  A T P ,  f o l l o w e d  b y  
phenol/chloroform/isoamyl  alcohol extraction and 
ethanol precipitation. The precipitate was dissolved in 
65 µl of 0.5 M phosphate buffer (pH 9.0) and then 
mixed with 10 µl of 0.025 M succinic  anhydride in 
DMSO for overnight at room temperature and purified 
on P6 column (Bio Rad) pre-equilibrated with H2O. 
Purified sample was mixed with 2 mg 
adipodihydrazide and 5 mg EDC (1-ethyl-3- 
(3-dimethylaminopropyl) carbodiimide) in 70 µl of 0.1 
M phosphate buffer (pH 7.2) for 4 hour at room 
temperature and purified on P6 column 
pre-equilibrated with H2O. 
The length of the DNA-linker used in this study 
was designed as follow. The local maximum 
concentration of two sites on a linear ssRNA chain 
(polyU) is described as: 
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where r is the distance-through-space between 
the two sites, n is the distance-through-bond in the 
number of Kuhn segment and l is statistical segment 
length or Kuhn length. For ssRNA, the number of 
Kuhn segment and Kuhn length were reported for 
polyU as ν/6 and 4 nm, respectively. 
The value of r for our case is 14 nm that is the 
distance-through-space between the exit position of 
mRNA on ribosome and the entrance of A-site of 
ribosome [21]. On the assumption that mRNA and the 
linker were composed of ssRNA, the probability Int. J. Biol. Sci. 2007, 3 
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distribution of local concentration of linked aminoacyl 
sup tRNA on the entrance of A-site of ribosome is 
given as: 
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According to Equation 3, the maximum local 
concentration 45.5 µM is obtained when the 
distance-through-bond  ν is 75 nt. Thus, the linker 
length was designed so that the chain length from the 
mRNA exit site to the 5’-terminus of the linker become 
equivalent to 75 nt. 
Construction of the mRNA-templates 
The His-tag encoding DNA (178 bp, Fig.2A) was 
constructed by three steps of PCR amplification. The 
first step PCR was performed using three oligomers; 
NL-temp (5’-ATGGGCTAGGGTGTGAGCAAGGGCG 
AGGAGCTGTTCACCGGGGCAGCGCATCAC-3’), 
prNL+ (5’-CGGTTTCCCTCTAGAAATAATTTTGTTT 
AACTTTAAGAAGGAGATATATCCATGGGCTAGG
GTGTGAGCA-3’) and prNL- (5’-ACTCCTTAATGAT 
GGTGATGGTGATGCGCTGCCCCGGT-3’) and the 
resulting dsDNA was further amplified using two 
primers; prNLφ2.5GC+ (5’- CAGTAATACGACTCAC 
TATTAGGGCCCCCCGACCCCGGTTTCCCTCTAGA
AATAATTTTGT–3’) and prNLHis- (5’-GCATCGACT 
CCTTAATGATGGTGATGGTGATGCGCTGCCCCG
GTG-3’). The final step PCR was performed using the 
second step product dsDNA and two primers; prRT+ 
(5’-CAGTAATACGACTCACTATTAGGGCCCCCCG
AC-3’) and prRT- (5’-GAATTCGCCCTTGCATCGAC 
TC-3’). The FLAG encoding DNA (190 bp, Fig.2A) was 
constructed by two steps of PCR amplification. The 
first step PCR was performed using the His-tag 
encoding DNA and two primers; prRT+ and 
prNLFLAG- (5’-GCATCGACTCCTTATTACTTGTCA 
TCGTCATCCTTGTAATCCGCCGCTGCCCCGGTGA
ACAG-3’) and the resulting dsDNA was further 
amplified using two primers; prRT+ and prRT-. These 
PCR products were purified using QIAquick PCR 
purification kit (Qiagen) and transcribed in vitro using 
RiboMAX TM Large Scale RNA Production System - T7 
(Promega) in the presence of 36 mM AMP and 3.6 mM 
each NTPs. The RNA transcript was purified on P6 
c o l u m n  t o  r e m o v e  e x c e s s  A M P ,  f o l l o w e d  b y  
phenol/chloroform/isoamyl  alcohol extraction and 
ethanol precipitation. 
 
Fig. 2. Constructs of DNA and mRNA used in this study. (A) Construct of the model dsDNA. (B) Constructs of mRNA and 
DNA-linker having hydrazide group and the complex in the ligation reaction. T7φ2.5, T7φ2.5 promoter; clump, GC-rich sequence 
for hybridization to the DNA-linker; ε, T7 gene 10 translation enhancer; SD, Shine-Dalgarno sequence; ATG or AUG, initiation 
codon; TAG or UAG, amber stop codon; GFPN, N-terminus 10 amino acids of Green Fluorescent Protein gene; 6x His, Histidine 
hexamer tag; FLAG, FLAG epitope tag, TAA or UAA, ocher stop codon; RTP, hybridization region for RT-primer prRT-; FITC, 
fluorescein isothiocyanate labeled to deoxythymidine. 
  
Ligation between the mRNA and the 
hydrazide-linker 
The mRNA (2 µM) was hybridized to the DNA 
moiety of the hydrazide-linker (4 µM) and prRT- (4 
µM) by heating at 95 °C and cooling to 25 °C in 50 µl of 
T4 RNA ligase buffer (Takara Bio) and ligation 
reaction was started by adding T4 RNA ligase (40 U, 
Takara Bio) and ribonuclease inhibitor (40 U, Takara 
Bio). Ligation reaction was performed at 25 °C for 
overnight and the ligated product was analyzed by 8 
M urea 8 % PAGE using TBE running buffer at 65 °C 
a n d  w e r e  v i s u a l i z e d  w i t h  f l u o r e s c e n c e  o f  F I T C  a n d  
then visualized again after staining by SYBR Green II 
(Cambrex) using a fluorescence imager (Pharos FX; 
Bio-Rad). Ligated product was purified using RNeasy 
Mini Kit (Qiagen). 
Preparation of amino acid substrate 
4-acetyl-L-phenylalanine cyanomethyl ester was 
s y n t h e s i z e d  b y  a s  f o l l o w s ;  1 0  m g  o f  
Boc-4-acetyl-L-phenylalanine (Chem Impex) was 
dissolved in 1 ml of acetonitrile and mixed with 350 µl 
of triethylamine and 100 µl of chloroacetonitrile. This 
mixture was stirred at room temperature for over night 
and the reaction mixture was diluted with 10 ml of Int. J. Biol. Sci. 2007, 3 
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ethyl acetate and extracted with 20 ml of 0.5 N HCl. 
The organic layer was then washed with 20 ml of 4 % 
NaHCO3  and 10 ml of saturated aqueous sodium 
chloride and dried using a rotary evaporator. The 
resulting residue was mixed with 250 µl of 
TFA/anisole mixture (9:1) and stirred at room 
temperature for 30 min. The solvent was removed 
using a rotary evaporator and 1 ml of 4 M HCl in 
dioxane was added to form the hydrochloride salt. The 
solution was concentrated using a rotary evaporator 
and 2 ml of ether was added to precipitate the 
hydrochloride salt. These reactions were traced by 
Thin Layer Chromatography. 
Preparation of aminoacyl-sup tRNA 
Aminoacyl-sup tRNA was prepared by the same 
procedure previously reported [22] with minor 
modification using 4-acetyl-L-phenylalanine 
cyanomethyl ester as the amino acid substrate.  
The template DNA encoding the aminoacyl 
ribozyme was constructed by two steps of PCR 
amplification. The first PCR was performed using 
three oligomers; Fx (5’-ACCTAACGCCAATACCCTT 
TCGGGCCTGCGGAAATCTTTCGATCC-3’), P5-1 
(5’-ACGCATATGTAATACGACTCACTATAGGATC
GAAAGATTTCCGC-3’) and P5-2 (5’-GGTAACACGC 
ATATGTAATACGACTC-3’). The resulting dsDNA 
was further amplified using two primers; p5-2 and 
p3-2 (5’-T20-ACCTAACGCC-3’). The template DNA 
encoding the engineered tRNAAsnCUA was constructed 
by two steps of PCR amplification. The first PCR was 
performed using three oligomers; tR 
(5’-TGGTGCCTCTGACTGGACTCGAACCAGTGAC
ATACGGATTTAGAGTCCGCCGTTCTACCGACTGA
ACTACAGAGGC-3’), p5-3 (5’-ACGCATATGTAATA 
CGACTCACTATAGCCTCTGTAGTTCAGTCGGT-3’) 
and p3-3 (5’-TGGTGCCTCTGACTGGACTC-3’). The 
resulting dsDNA was further amplified using two 
primers; p5-2 and p3-3. Amplified these two dsDNAs, 
encoding aminoacyl ribozyme or tRNAAsnCUA, were 
transcribed in vitro using RiboMAX TM  Large Scale 
RNA transcription System – T7 in the presence of 7.5 
mM GMP and 3.75 mM each NTPs. The RNA 
transcript was purified on P6 column to remove excess 
GMP, followed by phenol/chloroform/isoamyl 
alcohol extraction and ethanol precipitation. 
400 µl of 0.1 M NaIO4 was added to 1 ml of 30 µM 
ribozyme, and the mixture was incubated on ice for 20 
min. The oxidized RNA was then precipitated with 14 
ml of 2 % LiClO4 in acetone and washed with 1 ml 
acetone. The pellet was dissolved in 1.4 ml of 0.1 M 
sodium acetate (pH 5.0) and added to 0.7 ml of adipic 
acid dihydrazide-agarose (Sigma) that was prewashed 
with RNase-free water. The mixture was stirred at 
room temperature for three hour and then 300 µl of 1 
M NaBH3CN was added and the mixture was 
incubated for 30 min to stabilize the imine bond. The 
resin-immobilized ribozyme was washed with 1.4 ml 
of W1 (0.1 M sodium acetate, 300 mM NaCl, 7.5 M 
urea, 0.1% SDS, pH 5.0) and suspended in 2.1 ml of 
W1. 
30 µl of 50 µM tRNAAsnCUA was folded by heating 
at 95 °C and cooling to room temperature in a buffer 
(50 mM EPPS, 12.5 mM KCl, 12 mM MgCl2, pH 7.0) 
and then diluted in 15 µl of a buffer (50 mM EPPS, 12.5 
mM KCl, 3.6 M MgCl2, pH 7.0) and 20 µl of a buffer (50 
mM EPPS, 12.5 mM KCl, 1.2 M MgCl2, pH 7.0). The 
folded tRNA solution was mixed with 5 nmol of 
resin-immobilized ribozyme that was prewashed with 
RNase-free water, and then 12.5 µl of 100 mM 
4-acetyl-L-phenylalanine cyanomethyl ester in DMSO 
was added to this mixture followed by adding 1.6 µl of 
0.25 M KOH (to adjust pH to 7.0-7.2). After 2 hour 
incubation under rotation at 4 °C, EK buffer (50 mM 
EPPS, 12.5 mM KCl, 10 mM EDTA, pH 7.0) was added 
and the supernatant, containing aminoacyl-tRNA 
product, was recovered and ethanol precipitated. 
Confirmation of aminoacylation was performed as 
follows. 50 pmol of aminoacylated tRNA was 
dissolved in 5 µl of EPPS (0.1 M, pH 5.9) containing 20 
mM 6-(Biotinylamino)hexanoic acid 
N-hydroxy-sulfosuccinimide ester (Dojindo), and 1.0 
µl of EPPS-KOH (0.3 M, pH 9.1) was added to adjust 
pH to 8.0. The mixture was incubated for one hour on 
ice and ethanol precipitated. The pellet of biotinylated 
aminoacyl-tRNA was dissolved in 10 µl of the loading 
buffer (167 pmol streptavidin, 0.1 M sodium acetate, 8 
M urea, 0.05 % bromophenol blue, 0.05 % xylene 
cyanol, pH 5.0) and analyzed by 8 M urea 15 % PAGE 
using 50 mM sodium acetate (pH 5.0) as a running 
buffer at 30 °C and visualized after staining by SYBR 
Green II. 
 
Selective enrichment analysis 
10 pmol of the mRNA-linker ligation product 
encoding His-tag sequence was mixed with 100 pmol 
of 4-acetyl-phenylalanyl tRNAAsnCUA in 10 µl of 1 mM 
sodium acetate (pH 5.2) for overnight at room 
temperature and translated in 16 µl volume of E. coli 
S30 Extract System for Linear Templates (Promega) for 
5 min at 37 °C with SUPERase-In RNase inhibitor (20 
U, Ambion). The translated sample was incubated in 
100 µl of Ni-NTA agarose (Qiagen) suspended in wash 
buffer (50 mM NaH2PO4, 300 mM NaCl, 20 mM 
imidazole, pH 8.0) for 1 hour at 4 °C using a rotary 
mixer. The Ni-NTA agarose was washed two times 
with 200 µl of wash buffer and eluted with 50 µl of 
elution buffer (50 mM NaH2PO4, 300 mM NaCl, 250 
mM imidazole, pH 8.0). The eluted sample was 
desalted with MicroSpin G-25 Column  (GE 
Healthcare) and amplified by RT-PCR using C.therm. 
Polymerase One-Step RT-PCR System (Roche) using 
prRT+ and prRT- as primers. As negative controls, the 
translation product without methionine and the 
translation product without modification of 
4-acethyl-phenylalanine tRNAAsnCUA to the linker 
before translation were screened with Ni-NTA agarose 
and amplified by RT-PCR. The amplified products 
were analyzed by 8 M urea 8 % PAGE using TBE 
running buffer at 65 °C and visualized after staining by 
SYBR Green I (Cambrex). 
In selective enrichment analysis of the DNA 
encoding the His-tag sequence, Mixture of the Int. J. Biol. Sci. 2007, 3 
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mRNA-linker ligation products (1 pmol of the His-tag 
encoding molecule and 10 pmol of the FLAG-tag 
encoding molecule) was reacted with 100 pmol of 
4-acetyl-phenylalanyl tRNAAsnCUA i n  1 0  µ l  o f  1  m M  
sodium acetate (pH 5.2) for overnight at room 
temperature and translated in 16 µl volume of E. coli 
S30 Extract System for Linear Templates for 5 min at 37 
°C with SUPERase-In RNase inhibitor (20U). The 
translated sample was incubated in 100 µl of Ni-NTA 
agarose suspended in wash buffer (50 mM NaH2PO4, 
300 mM NaCl, 20 mM imidazole, pH 8.0) for 1 hour at 
4 °C using a rotary mixer. The Ni-NTA agarose was 
washed two times with 200 µl of wash buffer and 
eluted with 50 µl of elution buffer (50 mM NaH2PO4, 
300 mM NaCl, 250 mM imidazole, pH 8.0). The eluted 
sample was desalted with MicroSpin G-25 
Column  and amplified by RT-PCR using C.therm. 
Polymerase One-Step RT-PCR System using prRT+ 
and prRT- as primers. The amplified product was 
transcribed and ligated with hydrazide-linker for the 
next round of screening. The amplified product of each 
screening round was analyzed by 8 M urea 8 % PAGE 
using TBE running buffer at 65 °C and visualized after 
staining by SYBR Green I. 
In selective enrichment analysis of the DNA 
encoding the FLAG-tag sequence, Mixture of the 
mRNA-linker ligation products (1 pmol of FLAG-tag 
encoding molecule and 10 pmol of His-tag encoding 
molecule) was reacted with 100 pmol of 
4-acetyl-phenylalanyl tRNAAsnCUA i n  1 0  µ l  o f  1  m M  
sodium acetate (pH 5.2) for overnight at room 
temperature and translated in 16 µl reaction volume of 
E. coli S30 Extract System for Linear Templates 
(Promega) for 5 min at 37 °C with SUPERase-In RNase 
inhibitor (20U, Ambion). The translated sample was 
diluted in lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 
1 mM EDTA, 1 % Triton X-100, pH 8.0) and added to 
40 µl of anti-FLAG M2 agarose (Sigma), followed by 
incubation for 1 hour at 4 °C using a rotary mixer. The 
anti-FLAG agarose was washed three times with 500 µl 
lysis buffer and incubated with 100 µl of TBS 
containing 0.1 mg / ml of FLAG peptide for 1 hour at 4 
°C. The supernatant was desalted with MicroSpin G-25 
Column  and amplified by RT-PCR using C.therm. 
Polymerase One-Step RT-PCR System using prRT+ 
and prRT- as primers. The amplified product was 
transcribed and ligated with hydrazide-linker for the 
next round of screening. The amplified product of each 
screening round was analyzed by 8 M urea 8 % PAGE 
using TBE running buffer at 65 °C and visualized after 
staining by SYBR Green I. 
Selective enrichment of the DNA encoding the 
His-tag sequence using PURESYSTEM [23] was 
performed as follows. The mixture of the 
mRNA-linker ligation products (0.5 pmol of His-tag 
encoding molecule and 5 pmol of FLAG-tag encoding 
molecule) was reacted with 50 pmol of 
4-acetyl-phenylalanyl tRNAAsnCUA in 5 µl of 1 mM 
sodium acetate (pH 5.2) for overnight at room 
temperature and the reaction product was ethanol 
precipitated. The precipitated sample was translated in 
3.13 µl reaction volume of PURESYSTEM classic II 
(Post Genome Institute Co., Ltd.) for 15 min at 37 °C 
with SUPERase-In RNase inhibitor. The translated 
sample was incubated in 50 µl of Ni-NTA agarose 
suspended in wash buffer for 4 hour at 4 °C using a 
rotary mixer. The Ni-NTA agarose was washed five 
times with 400 µl of wash buffer and eluted with 100 µl 
of elution buffer. The eluted sample was desalted with 
MicroSpin G-25 Column  and amplified by RT-PCR 
using C.therm. Polymerase Two-Step RT-PCR System 
(Roche) and KOD dash DNA polymerase (Toyobo) 
using prRT+ and prRT-FITC (fluorescein was modified 
on the 5’-terminus of prRT-) as primers. The amplified 
product was analyzed by 8 M urea 8 % PAGE using 
TBE running buffer at 65 °C and visualized with 
fluorescence of FITC using a fluorescence imager. 
Selective enrichment of the DNA encoding the 
FLAG-tag sequence using PURESYSTEM was 
performed as follows. The mixture of the 
mRNA-linker ligation products (0.5 pmol of FLAG-tag 
encoding molecule and 5 pmol of His-tag encoding 
molecule) was reacted with 50 pmol of 
4-acetyl-phenylalanyl tRNAAsnCUA in 5 µl of 1 mM 
sodium acetate (pH 5.2) for overnight at room 
temperature and the reaction product was ethanol 
precipitated. The precipitated sample was translated in 
3.13 µl reaction volume of PURESYSTEM classic II for 
15 min at 37 °C with SUPERase-In RNase inhibitor. 
The translated sample was diluted in TBS buffer and 
added to 40 µl of anti-FLAG M2 agarose, followed by 
incubation for 4 hour at 4 °C using a rotary mixer. The 
anti-FLAG M2 agarose was washed five times with 400 
µl of TBS buffer and incubated with 100 µl of Elution 
buffer (0.1 M glycine-HCl, pH3.5) for 10 min at room 
temperature. The supernatant was desalted with 
MicroSpin G-25 Column  and amplified by RT-PCR 
using C.therm. Polymerase Two-Step RT-PCR System 
and KOD dash DNA polymerase using prRT+ and 
prRT-FITC as primers. The amplified product was 
analyzed by 8 M urea 8 % PAGE using TBE running 
buffer at 65 °C and visualized with fluorescence of 
FITC using a fluorescence imager. 
 
Detection of the mRNA-peptide fusion 
5 pmol of mRNA-linker ligation product was 
reacted with 50 pmol of 4-acetyl-phenylalanyl 
tRNAAsnCUA in 0.1 M sodium acetate (pH 5.2) for 
overnight at room temperature and the reaction 
product was ethanol precipitated. The precipitated 
pellet was translated in 6.25 µl reaction volume of 
PURESYSTEM classic II for 30 min at 37 °C with 
SUPERase-In RNase inhibitor. The translation product 
was blotted to PVDF-membrane after 15 % SDS-PAGE 
and labeled with anti-FLAG M2 monoclonal antibody 
(Sigma) as primary antibody and Cy3-linked 
anti-mouse IgG (GE Healthcare) as secondary 
antibody. Fluorescence of Cy3 was detected using a 
fluorescence imager. Int. J. Biol. Sci. 2007, 3 
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3.  Results and Discussions 
Ligation between the mRNA and the 
hydrazide-linker 
 
The connecting efficiency between the mRNA 
and the linker-molecule affects the diversity of the 
library. Thus, various sophisticated procedures have 
been devised [24-27]. In this report, we applied the 
Y-ligation method [25], which is the method of two 
single-strands ligation in the presence of a 
double-stranded stem to make a stem-loop structure in 
high efficiency. Because the transcripts were used as a 
phosphate donor substrate and the DNA moiety of 
hydrazide-linker were used as an acceptor substrate 
for T4 RNA ligase (Fig.2B), several modifications were 
required. First, transcription must be performed with 
excessive AMP (for T7φ2.5 promoter, GMP for normal 
T7 promoter and SP6 promoter) to generate the 
monophosphate at the 5’-terminus of the transcript 
and a riboadenosine must be attached to the 
3’-terminus of the DNA moiety of hydrazide-linker by 
terminal deoxyribonucleotidyl transferase to be 
recognized by T4 RNA ligase (Fig.2B) [28]. Unless 
these modifications were performed, the ligated 
product was hardly observed (data not shown). 
Second, since 3’-OH of the transcript can be ligated 
with 5’-monophosphate of itself, self-ligation of the 
transcript was occurred (Fig.3, lane 1-2). For blocking 
of the 3’-OH of the transcript, the DNA oligomer prRT- 
was hybridized to 3’-terminus region of the transcript 
before ligation reaction (Fig.2B). Self-ligation was 
effectively prevented (Fig.3, lane 4-5) and yield of 
desired product was increased from 10 % to 90 % 
(Fig.3B, lane 1 and 4). This blocking method is simple 
and effective compared with other methods (e.g., 
making 2’, 3’-cyclic phosphate group by self-cleavage 
of ribozyme placed at 3’-terminus [29,30] or cleavage 
with deoxyribozyme [31,32].). Third, it is reported that 
T4 RNA ligase does not prefer guanine residue as a 
phosphate donor [33,34], but common promoters for in 
vitro transcription start the transcription with guanine 
residue, which is located at 5’-terminus of transcripts 
and act as phosphate donor in ligation reaction. 
Therefore, it is suspected that the transcripts generated 
by guanine-initiation type promoter are not suitable 
for donor substrate of T4 RNA ligase. Hence, We 
applied T7φ2.5 promoter, which initiates the 
transcription with adenine residue [35], because 
adenine is better than guanine as a donor substrate of 
T4 RNA ligase [33,34]. We compared the ligation 
efficiency of transcripts generated by three kind of 
promoters; T7, SP6 and T7φ2.5. These promoters 
generate the fixed triplet sequence at 5’-terminus of the 
transcripts; GGG, GAA and AGG respectively. The 
transcript by T7φ2.5 promoter gave the best efficiency 
of over 80 %. For SP6 and T7, the efficiency saturated at 
about 55 % and 20 %, respectively (Fig.4). 
 
Fig. 3. Gel electrophoresis pattern of mRNA-linker ligation. 
The ligation products reacted with or without prRT- DNA 
oligomer used as a blocker of the 3’-end of mRNA were 
electrophoresis on 8 M urea 8 % PAGE at 65 °C and were 
visualized with fluorescence of (A) SYBR Green II and (B) 
FITC. Lane M: DNA ladder, Lane Y: ligation product, Lane L-: 
negative control, reaction product without DNA-linker, Lane 
E-: negative control, reaction product without T4 RNA ligase. 
Mobility of the mRNA-linker and the self-ligation product of 
mRNA are shown to be equivalent.  
 
Fig. 4. Time course of ligation reactions using three mRNAs 
transcribed by different promoters. Filled circle, open circle and 
triangle are ligation product of mRNA transcribed by T7φ2.5 
promoter, normal T7 promoter and SP6 promoter, respectively. 
 
Aminoacylation of tRNA and conjugation between 
hydrazide-linker and aminoacyl-tRNA 
 tRNAAsnCUA  was acylated with 
4-acetyl-L-phenylalanine using resin-immobilized 
ribozyme and aminoacylation efficiency was analyzed 
using a streptavidin-dependent gel-shift assay after 
biotinylation of the α-amino group of 
4-acetyl-L-phenylalanine. The efficiency was 
approximately 15 % in our procedure (Fig.5A). 
The yield of conjugation between 
mRNA-linker-hydrazide and 4-acetyl-L-phenylalanyl 
tRNAAsnCUA was estimated as follows. 7.5 pmol of Int. J. Biol. Sci. 2007, 3 
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hydrazide-linker and 75 pmol of 
4-acetyl-L-phenylalanyl tRNAAsnCUA were incubated in 
5 µl of 0.1 M sodium acetate (pH 5.2) for overnight at 
room temperature. The mixture was mixed with equal 
volume of loading buffer (0.1 M sodium acetate, 8 M 
urea, 0.05 % bromophenol blue, 0.05 % xylene cyanol, 
pH 5.0) and analyzed by 8 M urea 15 % PAGE using 50 
mM sodium acetate (pH 5.0) as a running buffer at 30 
°C and visualized with fluorescence of FITC and then 
visualized again after staining by SYBR Green II. The 
yield of the conjugation was approximately 10 % 
because of 90 % of hydrazide-linker was left without 
conjugation (Fig. 5B). This yield may be including the 
event of hydrolysis of aminoacyl-tRNA that has been 
conjugated to hydrazide-linker. 
Selective enrichment analysis 
We demonstrated a model selection experiment 
using a histidine-tag having high affinity to Ni2+. The 
translation product displaying the His-tag peptide was 
screened using a Ni-NTA agarose column. The bound 
sample was eluted and used as a template for RT-PCR. 
As negative controls, the translation product without 
methionine that is necessary to initiate translation and 
the translation product without modification of 
4-acethyl-phenylalanine sup tRNA to the linker before 
translation were screened with Ni-NTA agarose. The 
RT-PCR products were analyzed by electrophoresis 
and the desired product with higher amount was 
confirmed than one of negative controls generated by 
non-specific binding (Fig.6A). 
Next, we performed enrichment experiments for 
the DNA mixture. It was achieved to enrich the DNA 
encoding the His-tag sequence from a mixture 
containing an order of magnitude excess of the other 
DNA encoding FLAG-tag sequence (Fig.2A) in three 
rounds screening with Ni-NTA (Fig. 6B). Furthermore, 
enrichment of the DNA encoding the FLAG-tag 
sequence from a mixture containing an order of 
magnitude excess of the other DNA encoding His-tag 
sequence was also accomplished in single round 
screening with anti-FLAG M2 antibody (Fig. 6B). 
Additionally, we also performed enrichment 
experiments using another translation system 
(PURESYSTEM) and achieved the enrichment of 
desired sequence (Fig. 6C). These results indicated that 
the enrichment was not an artefact by nonspecific 
binding of displayed peptide but a fact by specific 
binding of each peptide sequence. 
Detection of the mRNA-peptide fusion 
The mRNA-linker ligation product encoding the 
FLAG peptide was translated and the mRNA-peptide 
fusion product was analy z e d  b y  S D S - P A G E  a n d  
western blotting. Although the migration of the band 
caused by fusion formation was not detected on 
SDS-PAGE (Fig. 7A), the fusion molecule was detected 
by the western blotting (Fig. 7B). This low yield of the 
fusion formation was corresponding to relatively low 
efficiency of the selective enrichment (Fig. 6B, C). The 
low yield (~10 %) of the linker-aminoacyl-tRNA 
conjugate (Fig. 5B) affected directly the yield of the 
final product. In general, non-natural amino acid 
possessing large side group was incorporated into 
protein with relatively low efficiency. However, it is 
also reported that incorporation efficiency was not 
dependent on size of side group but on its shape, and 
the linear shape was appropriate [36]. In addition, 
non-natural amino acids possessing relatively long 
side chain (BODIPY FL-X-aminophenylalanine [37] or 
ε-N-biotinyl-L-lysine [18,19,38]) were also successfully 
incorporated into the polypeptide. The side chain of 
the amino acid used in this study was linear and did 
not contain any large aromatic ring. However, since 
the side chain of the non-natural amino acid used in 
this study was extraordinarily long, this amino acid 
may be difficult to be incorporated into polypeptide or 
premature termination may be occur during peptide 
chain elongation if this amino acid was incorporated. 
The linker length also must affect the formation 
efficiency of the mRNA-peptide fusion. Therefore, 
experimental optimization of the linker length will 
give better efficiency although the length of the linker 
used in this study was optimized theoretically.  
 
Fig.5  Aminoacylation of tRNA
Asn
CUA and conjugation between aminoacyleted tRNA
Asn
CUA and hydrazide-linker. (A) Amino 
acylation of tRNA
Asn
CUA analyzed by streptavidin-dependent gel-shift assay. Approximately 15 % of tRNA was aminoacylated (Lane 
3). Lane 1, tRNA
Asn
CUA in the presence of SAv; Lane 2 and 5, tRNA
Asn
CUA in the absence of SAv; Lane 3, aminoacylated tRNA
Asn
CUA 
in the presence of SAv; Lane 4, aminoacylated tRNA
Asn
CUA in the absence of SAv. (B) Conjugation between aminoacylated 
tRNA
Asn
CUA and hydrazide-linker analyzed by acidic denatured PAGE. Approximately 10 % of hydrazide-linker was conjugated 
with aminoacylated tRNA
Asn
CUA (Lane 2). Lane 1, aminoacylated tRNA
Asn
CUA; Lane 2, conjugation product between aminoacylated 
tRNA
Asn
CUA and hydrazide-linker; Lane 3, hydrazide-linker. Int. J. Biol. Sci. 2007, 3 
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Fig. 6. Results of the 
selective enrichment 
experiment. (A) Result of 
RT-PCR after single-round 
Ni-NTA screening of the 
mRNA-peptide fusion 
displaying 6x His-tag 
sequence. Left panel, 
RT-PCR of the screened 
samples translated with or 
without methionine. Right 
panel, RT-PCR of the 
screened samples translated 
using mRNA with or 
without modification of 
4-acethyl-phenylalanyl 
tRNA
Asn
CUA before 
translation. Lane M: DNA 
ladder, Lane PC: positive 
control using mRNA before 
translation as template of 
RT-PCR. (B) Results of 
selective enrichment 
experiment for binary 
mixture: the FLAG-tag 
displaying fusion molecule 
and the 6x His-tag 
displaying fusion molecule. 
Initial molar ratio of the 
former to the latter is 87:13 
for left panel and 17:83 for 
right panel. RT-PCR 
product at each screening 
round was analyzed by 
electrophoresis. Left panel; 
screening with Ni-NTA 
column. Right panel; 
screening with Anti-FLAG 
antibody column. (C) 
Results of selective 
enrichment experiment 
using PURESYSTEM for 
binary mixture: the FLAG-tag displaying fusion molecule and the 6x His-tag displaying fusion molecule. Initial molar ratio of the 
former to the latter is 76:24 for left panel and 6:94 for right panel. RT-PCR product at each screening round was analyzed by 
electrophoresis. Left panel; screening with Ni-NTA column. Right panel; screening with Anti-FLAG antibody column. 
 
 
Fig. 7. Detection of mRNA-peptide fusion. The mRNA-linker ligation product that encoded FLAG peptide was translated and 
analyzed by the western blotting after SDS-PAGE separation. The fusion molecule was detected by the fluorescence of the Cy3 
labeled on the secondary anti-body. (A) SDS-PAGE separation visualized by the fluorescence of FITC labeled on the 
hydrazide-linker. (B) Western blotting analysis visualized by the fluorescence of the Cy3 labeled on the secondary anti-body. The 
arrowhead and asterisk indicate the fusion molecule and nonspecific band, respectively. Lane 1: mRNA-linker-hydrazide. Lane 2: 
translated sample. Lane 3: proteinase K treated sample after translation. Lane 4: translated sample incubated with unaminoacylated 
sup tRNA in place of aminoacyl-sup tRNA before translation. Lane 5: translated sample without mRNA template. 
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4.  Conclusion 
We have developed a new method to prepare an 
mRNA-peptide fusion molecule covalently linked via 
N-terminus during in vitro translation. Because this 
fusion molecule displays the C-terminus of the 
peptide, it makes it possible to selection of the peptides 
for which function the C-terminus is essential. And 
also because this fused molecule has the free 
3’-terminus of mRNA, it would make it possible to 
select an RNA replicase of de novo initiation-type.  
And because a stop codon is inserted near 
downstream of the initiation codon, the translation 
reaction terminates just after initiation unless the sup 
tRNA is incorporated. Therefore unfused peptides that 
must compete with the fused peptides are never 
generated. Furthermore, this system is able to work 
even if the mRNA contains a termination codon. This 
method may be extended to the fusion formation 
linked at any position of protein by changing the 
position of amber codon that corresponds to the 
incorporation site of the linked aminoacyl sup tRNA. 
Thus, it may be possible that displaying the protein 
which having free terminus at both end and that 
arbitrary selection of the linking point on the protein 
according to its structure. 
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